CAJ | 학술논문

目的：探讨机器人系统在卵巢癌手术中的应用价值。方法回顾性分析2014年11月至2015年5月期间收治的卵巢癌手术患者46例。其中机器人辅助腹腔镜手术（机器人手术组）14例（其中1例机器人探查后中转开腹手术），同期经腹手术（开腹手术组）25例，经腹腔镜手术（腹腔镜手术组）7例。所有患者统计年龄、术前新辅助化疗次数、手术时间、手术方式、术中出血量、术中并发症、术后并发症、病理类型、清扫淋巴结数、术后排气时间、术后住院时间，对相应数据进行分析。结果机器人系统完成手术共13例，其中Ⅰ-Ⅱ期手术7例，Ⅲ期手术4例，复发癌手术2例。腹腔镜手术组中1例腹腔镜探查后中转开腹手术。机器人手术组与腹腔镜手术组相比，术中出血量、清扫淋巴结数及术后排气时间均无明显差异。结论机器人手术组在卵巢癌分期手术中安全、可靠，手术效果同腹腔镜手术组类似。对于晚期或复发性卵巢癌等复杂的手术，机器人系统更有优势。
목적：탐토궤기인계통재란소암수술중적응용개치。방법회고성분석2014년11월지2015년5월기간수치적란소암수술환자46례。기중궤기인보조복강경수술（궤기인수술조）14례（기중1례궤기인탐사후중전개복수술），동기경복수술（개복수술조）25례，경복강경수술（복강경수술조）7례。소유환자통계년령、술전신보조화료차수、수술시간、수술방식、술중출혈량、술중병발증、술후병발증、병리류형、청소림파결수、술후배기시간、술후주원시간，대상응수거진행분석。결과궤기인계통완성수술공13례，기중Ⅰ-Ⅱ기수술7례，Ⅲ기수술4례，복발암수술2례。복강경수술조중1례복강경탐사후중전개복수술。궤기인수술조여복강경수술조상비，술중출혈량、청소림파결수급술후배기시간균무명현차이。결론궤기인수술조재란소암분기수술중안전、가고，수술효과동복강경수술조유사。대우만기혹복발성란소암등복잡적수술，궤기인계통경유우세。
Objectives To explore the application of robot system in the operation of ovarian cancer .Methods A total of 46 patients with ovarian cancer were retrospectively analyzed from Nov .2014 to May 2015 . 14 cases of the patients were performed by the robot . 25 cases were completed by laparotomyduring the same period .7 cases were performed by laparoscopic surgery .All the statistics were analized including the age , frequency of preoperative neoadjuvantchemotherapy , operation time, operationmethods, intraoperative blood loss , intraoperative and postoperative complications , pathological type, number of lymph nodes, postoperative exhaust time,time of anal exsufflation and hospitalization after operation.Results 13 cases of the pations with ovarian cancer were performed by robot to complete the operation, including 7 cases in stageⅠ-Ⅱ, 4 cases in stage Ⅲand 2 cases with recurrent cancer .There is not significantly differentin in blood loss , lymph node dissection ,the time of exhaust between the robot group and the laparoscopic group .Conclusions The robot is safe and reliable in the operation of ovarian cancer . The bleeding volume and time of anal postoperative exhaustwere similar to the laparoscopic operation .The robot system has more advantages in the complex operation , such as terminal stage or recurrent ovarian cancer.